AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W959. A total of 4 filers reported holding AMICUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,002,000 | -10.7% | 1,656 | +15.3% | 0.26% | -26.2% |
| Q2 2018 | $2,243,000 | -25.4% | 1,436 | -28.2% | 0.35% | +92.8% |
| Q1 2018 | $3,008,000 | +4.5% | 2,000 | 0.0% | 0.18% | -31.3% |
| Q4 2017 | $2,878,000 | +281.7% | 2,000 | +300.0% | 0.26% | +434.7% |
| Q3 2017 | $754,000 | -72.1% | 500 | -81.4% | 0.05% | -72.3% |
| Q2 2017 | $2,701,000 | +69.0% | 2,682 | +19.7% | 0.18% | +105.8% |
| Q1 2017 | $1,598,000 | +181.8% | 2,241 | +96.6% | 0.09% | +160.6% |
| Q4 2016 | $567,000 | -66.4% | 1,140 | -50.0% | 0.03% | -47.6% |
| Q3 2016 | $1,689,000 | +38.4% | 2,282 | +2.1% | 0.06% | -1.6% |
| Q2 2016 | $1,220,000 | -58.6% | 2,234 | -35.9% | 0.06% | -56.5% |
| Q1 2016 | $2,945,000 | -13.2% | 3,485 | -0.4% | 0.15% | -21.4% |
| Q4 2015 | $3,394,000 | +4.5% | 3,499 | +50.7% | 0.19% | +39.6% |
| Q3 2015 | $3,248,000 | +82.6% | 2,322 | +84.7% | 0.13% | +106.2% |
| Q2 2015 | $1,779,000 | -0.9% | 1,257 | -23.9% | 0.06% | -13.3% |
| Q1 2015 | $1,796,000 | +35.1% | 1,651 | +3.4% | 0.08% | +78.6% |
| Q4 2014 | $1,329,000 | – | 1,597 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,436 | $2,243,000 | 0.35% |
| GROUP ONE TRADING, L.P. | 105,200 | $1,643,000 | 0.01% |
| SIMPLEX TRADING, LLC | 756 | $1,180,000 | 0.01% |
| JPMORGAN CHASE & CO | 40,000 | $625,000 | 0.00% |